DigiFab anti-digoxin polyclonal antibody fragments regulatory update

PTI received FDA approval to market its Digifab antibody fragments to treat digoxin toxicity, a life-threatening dysrhythmia that can result from treatment with digoxin, a drug used to treat heart fai...